Synthesis and bioanalytical analysis of f small molecules for the NCATS Early Translational Branch Chemistry Program

Closed Solicitation Posted

Solicitation number
75N95024Q00563
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Durham, North Carolina 27707, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services, National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS) intends to award a sole-source contract for the synthesis and bioanalytical analysis of small molecules to support its Early Translational Branch Chemistry Program. The contract is classified under NAICS code 541380 for Testing Laboratories and Services. NCATS seeks these services to develop small molecule inhibitors of physiological small molecule methyltransferases. The contract will have a 12-month period of performance. Interested parties may submit capability statements by the closing date of September 6, 2024 at 4:00 pm EST, and must include details such as unit price, delivery period, and business size certification.

This procurement is not set-aside. The intended source is ChemoGenics BioPharma, which previously performed similar work under prior purchase orders. The estimated contract value is not provided, but the work is expected to be valued at approximately $230,000. The place of performance is Durham, North Carolina.

Notice text

NOTICE OF INTENT to Sole Source
1.    SOLICITATION NUMBER:
75N95024Q00563
2.    TITLE:  Synthesis and bioanalytical analysis of f small molecules for the NCATS Early Translational Branch Chemistry Program

3.    CLASSIFICATION CODE:
B504 – Special Studies/Analysis-Chemical/Biological
NAICS CODE: 541380 – Testing Laboratories and Services  
4.    RESPONSE DATE:
September 6, 2024 at 4:00 pm EST
5.    PRIMARY POINT OF CONTACT:
Michelle Cecilia    
Michelle.cecilia@nih.gov
Phone: 301.827.7199
6.    DESCRIPTION:
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). 

National Center for Advancing Translational Sciences (NCATS) intends to negotiate on a sole source basis with ChemoGenics BioPharma for the synthesis and bioanalytical analysis of small molecules for the NCATS  Early Translational Branch chemistry program.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS
The intended procurement is classified under NAICS code 541380 – Testing Laboratories and Services with a Size Standard of $19 Million.  

REGULATORY AUTHORITY 
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6—Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single source provides that: For purchases not exceeding the simplified acquisition threshold, Contracting Officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization).


The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2024-06 dated August 29, 2024.

DESCRIPTION OF REQUIREMENT
PURPOSE AND OBJECTIVES:
NCATS is in need of custom synthesis and bioanalytical services in internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases.

Period of Performance:
12 months ARO
 
CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION

The essential characteristics of the item or service that limit the availability to a sole source are:

This acquisition requires previous experience in the making of methyltransferase inhibitors. The service provided by this contractor will allow for continuity of research, consistency of data/results which is imperative in this project. Previous similar work was completed under PO # 75N98022D00019/75N98022F00005/P00003

The intended source is:
ChemoGenics BioPharma
3325 Durham Chapel Hill Blvd, Suite 250
Durham, NC  27707

CLOSING STATEMENT

THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice. 

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. 

Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by the closing date and time of this announcement and must reference the solicitation number 75N95023Q00571. Responses must be submitted electronically to Michelle Cecilia, Contracting Officer, at Michelle.Cecilia@nih.gov.  U.S. Mail and fax responses will not be accepted.

Files

File Type Posted
Attachment 1 SOW FINAL 8_30_24.pdf PDF
B SSJ_FS_FINAL.pdf PDF

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors